Diagnosis and management of meningococcal disease: The need for centralized care

FEMS Microbiology Reviews

Volumn 31, Issue 1, 2007, Pages 71-83

  Nadel, Simon ^a   Kroll, J Simon ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Management; Meningococcal disease; Pathophysiology

Indexed keywords

ADRENALIN; ALTEPLASE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; DEXAMETHASONE; DROTRECOGIN; ENDOTOXIN ANTIBODY; FUROSEMIDE; HA 1A ANTIBODY; LORAZEPAM; MANNITOL; MIDAZOLAM; NORADRENALIN; PARALDEHYDE; PENICILLIN G; PHENYTOIN; RIFAMPICIN; STEROID; THIOPENTAL; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANTIBIOTIC THERAPY; ASSISTED VENTILATION; BACTERIAL MENINGITIS; BRAIN HEMORRHAGE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG FATALITY; EPIDEMIC MENINGITIS; FLUID RESUSCITATION; HUMAN; INFECTION SENSITIVITY; INFLUENZA; INTENSIVE CARE; INTRACRANIAL PRESSURE; LOW DRUG DOSE; LUMBAR PUNCTURE; MENINGOCOCCOSIS; MORTALITY; PATHOPHYSIOLOGY; PATIENT CARE; RASH; RECOMMENDED DRUG DOSE; REVIEW; SEIZURE; SEPTICEMIA; SHOCK; SINGLE DRUG DOSE; SYMPTOM; WARD;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; GREAT BRITAIN; HUMANS; INTENSIVE CARE; INTRACRANIAL PRESSURE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; SEPSIS; SHOCK;

PICUS;

EID: 33846041765     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2006.00059.x     Document Type: Review

References (101)

1. Advanced Life Support Group (1997) Relative contraindications to lumbar puncture. Advanced Paediatric Life Support-The Practical Approach Group ALS ed), pp. 27. BMJ Publishing Group, London.
2. American Academy of Pediatrics (Meningococcal Infections). (2000) 2000 Red Book. Report of the Committee on Infectious Diseases (Pickering LK, ed), pp. 397. American Academy of Pediatrics, Elk Grove Village, IL.
3. Annane D, Sebille V, Charpentier C et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871.
4. Baker RC, Seguin JH, Leslie N, Gilchrist MJ & Myers MG (1989) Fever and petechiae in children. Pediatrics 84: 1051-1055.
5. Berild D, Gedde-Dahl TW & Abrahamsen T (1980) Meningococcal disease in the Norwegian Armed Forces 1967-1979. Some epidemiological aspects. NIPH Ann 3: 23-30.
6. Baker M, McNicholas A, Garrett N et al. (2000) Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr Infect Dis J 19: 983-990.
7. Bernard GR, Vincent JL, Laterre PF et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709.
8. Booy R, Habibi P, Nadel S et al. (2001) Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 85: 386-390.
9. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S & Sorensen E (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159: 195-204.
10. Britto J, Nadel S, Maconochie I, Levin M & Habibi P (1995) Morbidity and severity of illness during interhospital transfer: impact of a specialised paediatric retrieval team. Brit Med J 311: 836-839.
11. Carcillo JA & Fields AI (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30: 1365-1378.
12. Carcillo JA, Davis AL & Zaritsky A (1991) Role of early fluid resuscitation in pediatric septic shock. JAMA 266: 1242-1245.
13. Carrol ED, Thomson AP, Shears P, Gray SJ, Kaczmarski EB & Hart CA (2000) Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch Dis Child 83: 271-273.
14. Cartwright K & Kroll S (1997) Optimising the investigation of meningococcal disease. Brit Med J 315: 757-758.
15. Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB & Palmer SR (1991) Influenza A and meningococcal disease. Lancet 338: 554-557.
16. Cartwright K, Reilly S, White D & Stuart J (1992) Early treatment with parenteral penicillin in meningococcal disease. BMJ 305: 143-147.
17. Caugant DA, Høiby EA, Magnus P et al. (1994) Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 32: 323-330.
18. Chin RF, Neville BG, Peckham C, Bedford H, Wade A, Scott RC & The NLSTEPSS Collaborative Group. (2006) Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 368: 222-229.
19. Davies MS, Nadel S, Habibi P, Levin M & Hunt DM (2000) The orthopaedic management of peripheral ischaemia in meningococcal septicaemia in children. J Bone Joint Surg Br 82: 383-386.
20. De Wals P, Hertoghe L, Borlee-Grimee I et al. (1981) Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts. J Infect 3: S53-S61.
21. Derkx B, Wittes J & McCloskey R (1999) Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis 28: 770-777.
22. Edwards KM, Jones LM & Stephens DS (1985) Clinical features of mild systemic meningococcal disease with characterization of bacterial isolates. Clin Pediatr (Phila) 24: 617-620.
23. Emonts M, Hazelzet JA, de Groot R & Hermans PW (2003) Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3: 565-567.
24. Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131: 417-430.
25. Faust SN, Levin M, Harrison OB et al. (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345: 408-416.
26. Feigin RD & Pearlman E (1998) Bacterial meningitis beyond the neonatal period. Textbook of Pediatric Infectious Diseases. 4th edn (Feigin RD & Cherry JD, eds), pp. 400-429. WB Saunders Co., Philadelphia, PA.
27. Fijen CA, Kuijper EJ, Hannema AJ, Sjöholm AG & van Putten JP (1989) Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 2: 585-588.
28. Finfer S, Bellomo R, Boyce N, French J, Myburgh J & Norton R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247-2256.
29. Fischer M, Hedberg K, Cardosi P et al. (1997) Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J 16: 979-983.
30. Giroir B, Goldstein B, Nadel S, Wang D, Levy H & Williams M (2006) The efficacy of drotrecogin alfa (activated) for the treatment of pediatric severe sepsis. Crit Care Med 33: A152.
31. Gold R, Goldschneider I, Lepow ML, Draper TF & Randolph M (1978) Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 137: 112-121.
32. Grandgirard D & Leib SL (2006) Strategies to prevent neuronal damage in paediatric bacterial meningitis. Curr Opin Pediatr 18: 112-118.
33. Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, Borrow R, Mallard RH & Kaczmarski EB (2006) Epidemiology of meningococcal disease in England and Wales, 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit (Williams JD & Burnie J, eds). J Med Microbiol 55: 887-896.
34. Greenwood B (1987) The epidemiology of acute bacterial meningitis in tropical Africa. Bacterial Meningitis. 1st edn (AAAA, ed), pp. 61-91. Academic Press, London.
35. Haneberg B, Tonjum T, Rodahl K & Gedde-Dahl TW (1983) Factors preceding the onset of meningococcal disease, with special emphasis on passive smoking, symptoms of ill health. NIPH Ann 6: 169-173.
36. Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S & Levin M (2003) Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med 31: 2788-2793.
37. Harnden A, Ninis N, Thompson M, Perera R, Levin M, Mant D & Mayon-White R (2006) Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study. Brit Med J 332: 1295-1298.
38. Hatherill M, Tibby SM, Hilliard T, Turner C & Murdoch IA (1999) Adrenal insufficiency in septic shock. Arch Dis Child 80: 51-55.
39. Havens PL, Garland JS, Brook MM, Dewitz BA, Stremski ES & Troshynski TJ (1989) Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J 8: 8-11.
40. Heyderman RS, Robb SA, Kendall BE & Levin M (1992) Does computed tomography have a role in the evaluation of complicated acute bacterial meningitis in childhood? Dev Med Child Neurol 34: 870-875.
41. Kaczmarski EB (1997) Meningococcal disease in England and Wales: 1995. Commun Dis Rep CDR Rev 7: R55-9.
42. Khilnani P (1992) Electrolyte abnormalities in critically ill children. Crit Care Med 20: 241-250.
43. Kirkham FJ (2001) Non-traumatic coma in children. Arch Dis Child 85: 303-312.
44. Kirsch EA, Barton RP, Kitchen L & Giroir BP (1996) Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 15: 967-978.
45. Kumar A, Thota V, Dee L, Olson J, Uretz E & Parrillo JE (1996) Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183: 949-958.
46. Kuppermann N, Malley R, Inkelis SH & Fleisher GR (1999) Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics 103: E20.
47. Ledingham IM & McArdle CS (1978) Prospective study of the treatment of septic shock. Lancet 1: 1194-1197.
48. Lefering R & Neugebauer EA (1995) Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 23: 1294-1303.
49. Levin M, Quint PA, Goldstein B et al. (2000) Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356: 961-967.
50. Locker GJ, Wagner A, Peter A et al. (1995) Lethal Waterhouse-Friderichsen syndrome in posttraumatic asplenia. J Trauma 39: 784-786.
51. Lodder MC, Schildkamp RL, Bijlmer HA, Dankert J, Kuik DJ & Scholten RJ (1996) Prognostic indicators of the outcome of meningococcal disease: a study of 562 patients. J Med Microbiol 45: 16-20.
52. Lopez A, Lorente JA, Steingrub J et al. (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32: 21-30.
53. Maiden MC & Stuart JM (2002) Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359: 1829-1831.
54. Manchanda V & Bhalla P (2006) Emergence of Non-Ceftriaxone- Susceptible Neisseria meningitidis in India. J Clin Microbiol 44: 4290-4291.
55. Mandl KD, Stack AM & Fleisher GR (1997) Incidence of bacteremia in infants and children with fever and petechiae. J Pediatr 131: 398-404.
56. Marzouk O, Thomson AP, Sills JA, Hart CA & Harris F (1991) Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child 66: 485-487.
57. Matok I, Vard A, Efrati O et al. (2005) Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 23: 305-310.
58. McCloskey RV, Straube RC, Sanders C, Smith SM & Smith CR (1994) Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 121: 1-5.
59. McIntyre PB, Berkey CS, King SM et al. (1997) Dexamethasone as adjunctive therapy in bacterial meningitis. A meta- analysis of randomized clinical trials since 1988. JAMA 278: 925-931.
60. Mercier JC, Beaufils F, Hartmann JF & Azema D (1988) Hemodynamic patterns of meningococcal shock in children. Crit Care Med 16: 27-33.
61. Moodley JR, Coetzee N & Hussey G (1999) Risk factors for meningococcal disease in Cape Town. S Afr Med J 89: 56-59.
62. Nadel S (2001) Lumbar puncture should not be performed in meningococcal disease. Arch Dis Child 84: 375.
63. Nadel S, Levin M & Habibi P (1995) Treatment of meningococcal disease in childhood. Meningococcal Disease (Cartwright K, ed), pp. 207-243. John Wiley & Sons, Chichester, UK.
64. Nadel S, Newport MJ, Booy R & Levin M (1996) Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174: 878-880.
65. Nadel S, Joarder R, Gibson M, Stevens J, Britto J, Habibi P & Owens C (1999) Emergency cranial computed tomography in the management of acute febrile encephalopathy in children. J Accid Emerg Med 16: 403-406.
66. Nathan N, Borel T, Djibo A et al. (2005) Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 366: 308-313.
67. Neal KR, Nguyen-Van-Tam J, Monk P, O'Brien SJ, Stuart J & Ramsay M (1999) Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation. Epidemiol Infect 122: 351-357.
68. Nielsen HE, Koch C, Magnussen P & Lind I (1989) Complement deficiencies in selected groups of patients with meningococcal disease. Scand J Infect Dis 21: 389-396.
69. Ninis N, Phillips C, Bailey L et al. (2005) The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. Brit Med J 330: 1475-1480.
70. Norgard B, Sorensen HT, Jensen ES, Faber T, Schonheyder HC & Nielsen GL (2002) Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: a Danish population-based cohort study. J Infect 45: 144-151.
71. Odio CM, Faingezicht I, Paris M et al. (1991) The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 324: 1525-1531.
72. Ovstebo R, Brandtzaeg P, Brusletto B, Haug KB, Lande K, Hoiby EA & Kierulf P (2004) Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 42: 2980-2987.
73. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477.
74. Pathan N, Sandiford C, Harding SE & Levin M (2002) Characterization of a myocardial depressant factor in meningococcal septicemia. Crit Care Med 30: 2191-2198.
75. Pathan N, Faust SN & Levin M (2003) Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child 88: 601-607.
76. Pathan N, Hemingway CA, Alizadeh AA et al. (2004) Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 363: 203-209.
77. Perkins MD, Mirrett S & Reller LB (1995) Rapid bacterial antigen detection is not clinically useful. J Clin Microbiol 33: 1486-1491.
78. Pollard AJ, DeMunter C, Nadel S & Levin M (1997) Abandoning empirical antibiotics for febrile children. Lancet 350: 811-812.
79. Pollard AJ, Probe G, Trombley C et al. (2002) Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak. Arch Pathol Lab Med 126: 1209-1215.
80. Rennick G, Shann F & de Campo J (1993) Cerebral herniation during bacterial meningitis in children. BMJ 306: 953-955.
81. Riordan FA, Marzouk O, Thomson AP, Sills JA & Hart CA (2002) Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods. Eur J Pediatr 161: 531-537.
82. Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377.
83. Roine I, Ledermann W, Foncea LM, Banfi A, Cohen J & Peltola H (2000) Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery. Pediatr Infect Dis J 19: 219-222.
84. Rosenstein NE, Perkins BA, Stephens DS et al. (1999) The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 180: 1894-1901.
85. Salit IE (1981) Meningococcemia caused by serogroup W135. Association with hypogammaglobulinemia. Arch Intern Med 141: 664-665.
86. Sarnaik AP & Lieh-Lai MW (1993) Transporting the neurologically compromised child. Pediatr Clin North Am 40: 337-354.
87. Sorensen HT, Nielsen GL, Schonheyder HC et al. (1998) Outcome of pre-hospital antibiotic treatment of meningococcal disease. J Clin Epidemiol 51: 717-721.
88. Stiehm ER & Damrosch DS (1966) Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr 68: 457-467.
89. Thiru Y, Pathan N, Bignall S, Habibi P & Levin M (2000) A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock. Crit Care Med 28: 2979-2983.
90. Thompson MJ, Ninis N, Perera R et al. (2006) Clinical recognition of meningococcal disease in children and adolescents. Lancet 367: 397-403.
91. Thorburn K, Baines P, Thomson A & Hart CA (2001) Mortality in severe meningococcal disease. Arch Dis Child 85: 382-385.
92. Tunkel AR & Scheld WM (1993) Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 6: 118-136.
93. van de Beek D, de Gans J, McIntyre P & Prasad K (2004) Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 4: 139-143.
94. van den Berghe G, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367.
95. van Deuren M, Brandtzaeg P & van der Meer JW (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13: 144-166.
96. Van Nguyen Q, Nguyen EA & Weiner LB (1984) Incidence of invasive bacterial disease in children with fever and petechiae. Pediatrics 74: 77-80.
97. Vincent JL, Nadel S, Kutsogiannis DJ et al. (2005) Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 9: R331-43.
98. Wakai A, Roberts I & Schierhout G (2005) Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev CD001049.
99. Yusuf HR, Rochat RW, Baughman WS et al. (1999) Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996. Am J Public Health 89: 712-717.
100. Zaritsky AL, Nadkarni VM & Hickey RW, et al., (eds).(2002) Pediatric Advanced Life Support Provider Manual. American Heart Association, Dallas, TX.
101. Zenz W, Zoehrer B, Levin M et al. (2004) Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study. Crit Care Med 32: 1777-1780.